Hasil Pencarian - Jia Li Low

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer

    The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer oleh Jia Li Low, Robert J. Walsh, Yvonne Ang, Gloria Chan, Ross A. Soo

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Advances in the management of non-small-cell lung cancer harbouring exon 20 insertion mutations

    Advances in the management of non-small-cell lung cancer harbouring exon 20 insertion mutations oleh Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)

    Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank) oleh Jia Li Low, Yiqing Huang, Kenneth Sooi, Zhi Yao Chan, Wei Peng Yong, Wei Peng Yong, Soo Chin Lee, Soo Chin Lee, Soo Chin Lee, Boon Cher Goh, Boon Cher Goh, Boon Cher Goh

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer

    Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer oleh Yiqing Huang, Joseph J. Zhao, Yu Yang Soon, Alvin Wong, Folefac Aminkeng, Yvonne Ang, Yugarajah Asokumaran, Jia Li Low, Matilda Lee, Joan R. E. Choo, Gloria Chan, Adrian Kee, Sen Hee Tay, Boon Cher Goh, Ross A. Soo

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

    Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia oleh Jia Li Low, Elaine Lim, Lavina Bharwani, Andrea Wong, Karmen Wong, Samuel Ow, Siew Eng Lim, Matilda Lee, Joan Choo, Joline Lim, Gloria Chan, Robert John Walsh, Vaishnavi Muthu, Natalie Ngoi, Wanqin Chong, Sing Huang Tan, Soo Chin Lee

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: